1068 (1068) Fair Value & Analysis

Consumer Defensive · Market cap HK$144M

1 1068 1068 · HK

PriceHK$0.0790

Fair ValueHK$0.0950

Upside+20.2%

Quality37/100

Evidence: Low Range HK$0.0892 – HK$0.1034

Fair value as of: Jul 2, 2026

From 4 valuation models · updated today

Share price −16.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0780 – HK$0.1800 · fair‑value band HK$0.0892 – HK$0.1034 · the HK$0.0790 price screens below the HK$0.0950 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1068 (1068) currently trades at HK$0.0790, while our model-based Fair Value estimate is HK$0.0950 — implying the stock looks roughly 20.2% undervalued today. We read business quality at 37/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 1068 generated revenue of HK$446M at a net margin of -16.0%. Revenue declined 57.8% year over year. Net debt stands at HK$419M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$446M

Revenue growth (YoY) -57.8%

Net margin -16.0%

Free cash flow −HK$40.6M FY2025

Operating margin -21.0%

EPS (TTM) HK$-0.0100

More key figures

Net debt HK$419M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1068 reported revenue of HK$446M in FY2025 versus HK$8.4B in FY2021, a compound −52.0%/yr. Reported net income was −HK$71.2M in FY2025.

Revenue −52.0%/yr

FY21 HK$8.4B

FY22 HK$2.2B

FY23 HK$1.4B

FY24 HK$992M

FY25 HK$446M

Net income

FY21 HK$3.1B

FY22 −HK$15.0M

FY23 −HK$148M

FY24 −HK$38.6M

FY25 −HK$71.2M

Is 1068 fairly valued? → Check now

Similar stocks

6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Nestlé S.A NESN	CHF 79.00	CHF 57.28	-27%
Foshan Haitian Flavouring and Food Company 603288	¥33.04	¥25.65	-22%
Nestlé India Limited NESTLEIND	₹1,438	₹362.37	-75%
Grupo Bimbo, S.A. BIMBOA	57.10 MXN	83.34 MXN	+46%
Uni-President Enterprises Corp 1216	75.10 TWD	72.54 TWD	-3%
Britannia Industries Limited BRITANNIA	₹5,218	₹3,567	-32%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1068 (1068) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0950 versus a price of HK$0.0790 — about +20% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1068?

Our model-based fair value for 1068 is HK$0.0950 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0790.

What is the quality score of 1068?

1068 has a Quality Score of 37/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1068 (1068)?

1068 reported trailing-twelve-month revenue of about HK$446M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1068?

The net profit margin of 1068 is about -16.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.